Company Financials

Harrow Health, Inc. Financials

United States dollar

business Harrow Health, Inc. Company Profile

Main Stock Listing

NASDAQ: HROW

Market Capitalization $1.17 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 5, 2025

Trailing PE -64.80
Forward PE 30.83
Price to Sales TTM $5.47
Price to Book MRQ $20.06
Enterprise to Revenue 6.02
Enterprise to EBITDA 65.62

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin -10.19%
Operating Margin -23.48%
Return on Assets TTM 0.90%
Return on Equity TTM -37.31%

Income Statement

Revenue TTM $212,858,000
Revenue per Share TTM $5.96
Quarterly Revenue Growth 38.30%
Gross Profit TTM $158,642,000
EBITDA $23,427,000
Net Income to Common TTM $-21,696,000
Diluted EPS TTM $-0.61
Quarterly Earnings Growth YoY 38.29%

Balance Sheet

Total Cash MRQ $70,183,000
Total Cash per Share MRQ $1.91
Total Debt MRQ $
Total Debt to Equity MRQ 410.02
Current Ratio MRQ 0.91
Book Value per Share MRQ $1.58

Cash Flow

Operating Cash Flow TTM $2,094,000
Levered Free Cash Flow TTM $-26,880,500

HROW Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding 35,622,214
Float Shares 27,213,453
Avg 10 Volume 367,630
Avg 30 Volume None
Shares Short 4,064,795
Short Ratio 9.05
Short % of Shares 14.00%
% Held by Insiders 15.07%
% Held by Institutions 57.11%

Stock Price Summary

Beta 0.40
Fifty Two Week Low $20.85
Fifty Two Week High $59.23
Fifty Two Week Change 29.26%
Day 50 MA $28.02
Day 200 MA $34.40

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2013-02-08